Home Medicine Stability of direct renin concentration and plasma renin activity in EDTA whole blood and plasma at ambient and refrigerated temperatures from 0 to 72 hours
Article
Licensed
Unlicensed Requires Authentication

Stability of direct renin concentration and plasma renin activity in EDTA whole blood and plasma at ambient and refrigerated temperatures from 0 to 72 hours

  • Sophie Hepburn ORCID logo EMAIL logo , Coral Munday , Kevin Taylor and David J. Halsall ORCID logo
Published/Copyright: July 4, 2022

Abstract

Objectives

The aim of this study was to determine the appropriate transport and storage conditions for blood taken for direct renin concentration and plasma renin activity measurement, and whether cryoactivation of prorenin is seen at time points relevant to clinical practice.

Methods

Blood was extracted from n=10 volunteers into K2-EDTA tubes. Stability of renin was assessed in whole blood stored at room temperature (15–25 °C) and in the refrigerator (2–8 °C) at 0 h, 8 h, and 24 h. The stability of renin in plasma was determined under the same conditions at 0 h, 24 h and 72 h.

Results

Stability of plasma renin activity and direct renin concentration in whole blood stored at room temperature was found to be acceptable for up to 24 h. At refrigerated temperature, whole blood stability was acceptable for measurement of direct renin concentration up to 8 h and plasma renin activity up to 24 h. In contrast, plasma renin activity was not stable in plasma stored at either room or refrigerated temperatures up to 24 h; however, direct renin concentration had acceptable stability in plasma stored at room temperature for up to 24 h, but stability was unacceptable at refrigerated temperatures.

Conclusions

Samples collected for plasma renin activity and direct renin concentration should be transported as whole blood to optimise stability. After sample processing, plasma can be kept at room temperature for up to 24 h for direct renin concentration, however, for determination of plasma renin activity separated plasma should be analysed or frozen as soon as possible.


Corresponding author: Sophie Hepburn, Blood Sciences, NHS Highland, Raigmore Hospital, IV2 3UJ Inverness, Scotland, UK, Phone: +441463 704 506, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Not applicable.

References

1. Saravi, B, Li, Z, Lang, CN, Schmid, B, Lang, FK, Grad, S, et al.. The tissue renin-angiotensin system and its role in the pathogenesis of major human diseases: quo vadis? Cells 2021;10:1–23. https://doi.org/10.3390/cells10030650.Search in Google Scholar

2. El-Asmar, N, Rajpal, A, Arafah, BM. Primary hyperaldosteronism: approach to diagnosis and management. Med Clin 2021;105:1065–80. https://doi.org/10.1016/j.mcna.2021.06.007.Search in Google Scholar

3. Hsueh, WA, Baxter, JD. Human prorenin. Hypertension 1991;17:469–77. https://doi.org/10.1161/01.hyp.17.4.469.Search in Google Scholar

4. Pitarresi, TM, Rubattu, S, Heinrikson, R, Sealey, JE. Reversible cryoactivation of recombinant human prorenin. J Biol Chem 1992;267:11753–9. https://doi.org/10.1016/s0021-9258(19)49762-7.Search in Google Scholar

5. Sealey, JE, Atlas, SA, Laragh, JH, Silverberg, M, Kaplan, AP. Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to Kallikrein. Proc Natl Acad Sci U S A 1979;76:5914–8. https://doi.org/10.1073/pnas.76.11.5914.Search in Google Scholar PubMed PubMed Central

6. Osmond, DH, Ross, LJ, Scaiff, KD. Increased renin activity after cold storage of human plasma. Can J Physiol Pharmacol 1973;51:705–8. https://doi.org/10.1139/y73-107.Search in Google Scholar PubMed

7. Sealey, JE. Plasma renin activity and plasma prorenin assays. Clin Chem 1991;37:1811–9. https://doi.org/10.1093/clinchem/37.10.1811.Search in Google Scholar

8. Lapworth, R, Green, SE, Short, F. In vitro stability of assayed renin activity in plasma and whole blood. Ann Clin Biochem 1990;27:78–9. https://doi.org/10.1177/000456329002700117.Search in Google Scholar PubMed

9. Stirati, G, de Martino, A, Menè, P, Pierucci, A, Simonetti, BM, Feriozzi, S, et al.. Plasma renin activity: effect of temperature during blood processing. J Clin Chem Clin Biochem 1983;21:529–31.Search in Google Scholar

10. Brossaud, J, Corcuff, JB. Pre-analytical and analytical considerations for the determination of plasma renin activity. Clin Chim Acta 2009;410:90–2. https://doi.org/10.1016/j.cca.2009.09.018.Search in Google Scholar PubMed

11. Locsei, Z, Racz, K, Patocs, A, Kovacs, GL, Toldy, E. Influence of sampling and storage conditions on plasma renin activity and plasma renin concentration. Clin Chim Acta 2009;402:203–5. https://doi.org/10.1016/j.cca.2009.01.013.Search in Google Scholar PubMed

12. Ulmer, PS, Meikle, AW. Sample requirements for plasma renin activity and immunoreactive renin. Clin Chem 2000;46:1442–4. https://doi.org/10.1093/clinchem/46.9.1442a.Search in Google Scholar

13. Rutledge, AC, Johnston, A, Bailey, D, Booth, RA, Edmond, P, Leung, V, et al.. Survey of renin and aldosterone testing practices by Ontario laboratorios – providing insight into best practices. Pract Lab Med 2021;25:e00229. https://doi.org/10.1016/j.plabm.2021.e00229.Search in Google Scholar PubMed PubMed Central

14. Cornes, M, Simundic, AM, Cadamuro, J, Costelloe, SJ, Baird, G, Kristensen, GBB, et al.. The CRESS checklist for reporting stability studies: on behalf of the European federation of clinical chemistry and laboratory medicine (EFLM) working group for the preanalytical phase (WG-PRE). Clin Chem Lab Med 2020;59:59–69. https://doi.org/10.1515/cclm-2020-0061.Search in Google Scholar PubMed

15. Simundic, A-M, Bölenius, K, Cadamuro, J, Church, S, Cornes, MP, van Dongen-Lases, EC, et al.. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med 2018;56:2015–38. https://doi.org/10.1515/cclm-2018-0602.Search in Google Scholar PubMed

16. Sealey, JE, Blumenfeld, J, Laragh, JH. Prorenin cryoactivation as a possible cause of normal renin levels in patients with primary hyperaldosteronism. J Hypertens 2005;23:459–60. https://doi.org/10.1097/00004872-200502000-00030.Search in Google Scholar PubMed

17. Hillebrand, JJ, Heijboer, AC, Endert, E. Effects of repeated freeze-thaw cycles on endocrine parameters in plasma and serum. Ann Clin Biochem 2017;54:289–92. https://doi.org/10.1177/0004563216657361.Search in Google Scholar PubMed

18. Gruson, D, Maisin, D, Lison, P, Maiter, D, Persu, A. Two-site automated chemiluminescent assay for measurement of immunoreactive renin. Biomarkers 2011;16:605–9. https://doi.org/10.3109/1354750x.2011.614015.Search in Google Scholar

19. Van Der Gugten, JG, Holmes, DT. Chapter 26. Quantitation of plasma renin activity in plasma using liquid-chromatography – tandem mass spectrometry (LC-MS/MS). In: Garg, U, editor. Clinical applications of mass spectrometry in biomolecular analysis. Methods in Molecular Biology. New York: Humana Press; 2016, vol 1378.10.1007/978-1-4939-3182-8_26Search in Google Scholar PubMed

20. Aarsand, AK, Fernandez-Calle, P, Webster, C, Coskun, A, Gonzales-Lao, E, Diaz-Garzon, J, et al. The EFLM biological variation database. Available from: https://biologicalvariation.eu/search?q=renin [Accessed 17 Jan 2022].Search in Google Scholar

21. Gómez-Rioja, R, Amaro, MS, Diaz-Garzón, J, Baucà, JM, Espartosa, DM, Fernández-Calle, P. A protocol for testing the stability of biochemical analytes. Technical document. Clin Chem Lab Med 2019;57:1829–36. https://doi.org/10.1515/cclm-2019-0586.Search in Google Scholar PubMed

22. Center for Biomathematics, Columbia University Medical Center. Available from: biomath.info [Accessed 28 Mar 2021].Search in Google Scholar

23. Chakera, AJ, McDonald, TJ, Knight, BA, Vaidya, B, Jones, AG. Current laboratory requirements for adrenocorticotropic hormone and renin/aldosterone sample handling are unnecessarily restrictive. Clin Med (London) 2017;17:18–21. https://doi.org/10.7861/clinmedicine.17-1-18.Search in Google Scholar PubMed PubMed Central

24. Carter, S, Owen, LJ, Kerstens, MN, Dullaart, RPF, Keevil, BG. A liquid chromatography tandem mass spectrometry assay for plasma renin activity using online solid-phase extraction. Ann Clin Biochem 2012;49:570–9. https://doi.org/10.1258/acb.2012.011186.Search in Google Scholar PubMed

25. Glinicki, P, Jeske, W, Gietka-Czernel, M, Bednarek-Papierska, L, Kruszyńska, A, Słowińska-Srzednicka, J, et al.. The effect of blood collection procedure on plasma renin activity (PRA) and concentrations of direct renin (DRC) and aldosterone. J Renin-Angiotensin-Aldosterone Syst JRAAS 2015;16:339–43. https://doi.org/10.1177/1470320313494434.Search in Google Scholar PubMed

26. Campbell, DJ, Nussberger, J, Stowasser, M, Jan Danser, AH, Morganti, A, Frandsen, E, et al.. Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem 2009;55:867–77. https://doi.org/10.1373/clinchem.2008.118000.Search in Google Scholar PubMed

27. Sealey, JE, Gordon, RD, Mantero, F. Plasma renin and aldosterone measurements in low renin hypertensive states. Trends Endocrinol Metab 2005;16:86–91. https://doi.org/10.1016/j.tem.2005.02.006.Search in Google Scholar PubMed

28. Hsueh, WA, Luetscher, JA, Carlson, EJ, Grislis, G, Fraze, E, McHargue, A. Changes in active and inactive renin throughout pregnancy. J Clin Endocrinol Metab 1982;54:1010–6. https://doi.org/10.1210/jcem-54-5-1010.Search in Google Scholar PubMed

29. Rowe, J, Gallery, ED, Gyory, AZ. Cryoactivation of renin in plasma from pregnant and nonpregnant subjects, and its control. Clin Chem 1979;25:1972–4. https://doi.org/10.1093/clinchem/25.11.1972.Search in Google Scholar

Received: 2022-04-18
Accepted: 2022-06-22
Published Online: 2022-07-04
Published in Print: 2022-08-26

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. Clinical Chemistry and Laboratory Medicine: enjoying the present and assessing the future
  4. Rethinking internal quality control: the time is now
  5. Review
  6. Multi-omics analysis from archival neonatal dried blood spots: limitations and opportunities
  7. Opinion Papers
  8. ‘Penelope test’: a practical instrument for checking appropriateness of laboratory tests
  9. Interference by macroprolactin in assays for prolactin: will the In Vitro Diagnostics Regulation lead to a solution at last?
  10. EFLM Paper
  11. Efficiency, efficacy and subjective user satisfaction of alternative laboratory report formats. An investigation on behalf of the Working Group for Postanalytical Phase (WG-POST), of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
  12. General Clinical Chemistry and Laboratory Medicine
  13. Cross-reactivity in assays for prolactin and optimum screening policy for macroprolactinaemia
  14. Repository of intra- and inter-run variations of quantitative autoantibody assays: a European multicenter study
  15. Stability of direct renin concentration and plasma renin activity in EDTA whole blood and plasma at ambient and refrigerated temperatures from 0 to 72 hours
  16. Comparison of four different immunoassays and a rapid isotope-dilution liquid chromatography-tandem mass spectrometry assay for serum folate
  17. Analytical quality specifications in semen analysis according to the state of the current methodologies
  18. Reference Values and Biological Variations
  19. Short-term biological variation study of plasma hemophilia and thrombophilia parameters in a population of apparently healthy Caucasian adults
  20. First morning voided urinary gonadotropins in children: verification of method performance and establishment of reference intervals
  21. Derivation of sex and age-specific reference intervals for clinical chemistry analytes in healthy Ghanaian adults
  22. Cancer Diagnostics
  23. Serum free light chain analysis: persisting limitations with new kids on the block
  24. Cardiovascular Diseases
  25. Age partitioned and continuous upper reference limits for Ortho VITROS High Sensitivity Troponin I in a healthy paediatric cohort
  26. The predictive value of hemoglobin to creatinine ratio for contrast-induced nephropathy in percutaneous coronary interventions
  27. Infectious Diseases
  28. Health technology assessment to employ COVID-19 serological tests as companion diagnostics in the vaccination campaign against SARS-CoV-2
  29. Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay
  30. Presepsin levels in neonatal cord blood are not influenced by maternal SARS-CoV-2 infection
  31. Letters to the Editors
  32. How to evaluate fixed clinical QC limits vs. risk-based SQC strategies
  33. Reply to Westgard et al.: ‘Keep your eyes wide … as the present now will later be past’*
  34. Platelet phagocytosis by monocytes
  35. Early detection of Candida parapsilosis in peripheral blood as a result of a peripheral blood smear performed after cytographic changes on the Beckman Coulter UniCel DxH 800 hematology
  36. Pseudo-erythroblastosis on Sysmex XN hematology analyzers: a clue to Candida sepsis. Case report and literature review
  37. Covert poisoning with difenacoum: diagnosis and follow-up difficulties
  38. Comparison of Sebia Capillarys 3-OCTA with the Tosoh Bioscience HLC®-723G8 method for A1C testing with focus on analytical interferences and variant detection
Downloaded on 17.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2022-0375/html?lang=en
Scroll to top button